Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Advanced Oncotherapy PLC Signs Heads Of Terms To Make Substantial Acquisition


Monday, 18 Feb 2013 02:00am EST 

Advanced Oncotherapy PLC announced that it has signed heads of terms to make a substantial acquisition of a company that has developed technology for treating cancerous tumours using affordable, cost-effective proton therapy techniques. The consideration for the proposed acquisition is to be satisfied by the issue of new Ordinary Shares in the Company. Financial terms were not disclosed. 

Company Quote

2.825
0.075 +2.73%
11 Jul 2014